James W. Hopper, PhD

Dr. Jim Hopper is an independent consultant and Teaching associate in psychology at Harvard Medical School, and consultant to the Outpatient Addictions Service of the Cambridge Health Alliance. For over 25 years, Dr. Hopper’s research and consulting work has focused on the psychological and biological effects of child abuse, sexual assault, and other traumatic experiences. As a clinician, Dr. Hopper works with traumatized adults. He was a therapist for the FDA-approved phase 3 trial of MDMA-Assisted Therapy for PTSD, and since 2020 has provided ketamine-assisted psychotherapy in private practice. Dr. Hopper consults and teaches nationally and internationally to clinicians as well as investigators, prosecutors, judges, and other professionals.

Speaker Disclosures:
Financial: James Hopper maintains a private practice and has employment relationships with Harvard Medical School and Cambridge Health Alliance. He receives royalties as a published author. James Hopper receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: James Hopper serves on the advisory board for Callisto. He is a member of the International Society for Traumatic Stress Studies and the APA Division 56. James Hopper is an Ad hoc reviewer for several peer review journals, for a complete list contact PESI, Inc.